Dr Perry is a Professor of Medicine (Neurology) at the University of Toronto.

Trained in Neurology in Toronto, clinical epidemiology, and Neuro-Oncology Fellowship at Duke University. He had been a neuro-oncologist at Sunnybrook Odette Cancer Centre since 1996. Founder and elected Chair and CEO of the Canadian Brain Tumour Consortium, Canadas largest brain tumour clinical trials network. He has led and participated in many practice changing clinical trials including the RESCUE study of daily metronomic temozolomide, the CCTG study of elderly GBM, and the INDIGO trial of vorasidenib. He has served as provincial lead for CNS Cancers in Ontario and serves on a wide variety of editorial boards, advisory boards, and guidelines committees. He is supported by the University of Toronto Crolla Family Endowed Chair in brain tumour research.